{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T16:11:59Z","timestamp":1753891919204,"version":"3.41.2"},"reference-count":36,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,1,29]],"date-time":"2024-01-29T00:00:00Z","timestamp":1706486400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:p>This case study documents an extraordinary disease progression in a 70-year-old patient diagnosed with metastatic melanoma. The patient\u2019s condition advanced to an unusual manifestation characterized by generalized melanosis and melanuria, a rare and foreboding complication of metastatic melanoma. The clinical presentation involved rapid-onset skin darkening, primarily affecting the face and torso, along with darkened urine, marking the onset of melanuria. Despite extensive diagnostic evaluations, including abdominal ultrasound, neck ultrasound, thoracic CT scans, and endoscopic examinations, the exact metastatic sites remained elusive, demonstrating the diagnostic challenges associated with this condition. Laboratory tests revealed abnormal hematological and biochemical markers, along with elevated S100 protein levels, indicating disease progression. The patient underwent a surgical skin biopsy that confirmed the diagnosis of metastatic melanoma, leading to a multidisciplinary approach to treatment. Following this, the patient-initiated chemotherapy with dacarbazine (DTIC). Regrettably, this was necessitated by the absence of reimbursement for BRAF and MEK inhibitors as well as immunotherapy, and it subsequently led to rapid disease progression and a decline in the patient\u2019s clinical condition. The patient\u2019s condition further complicated with erysipelas and increased distress, ultimately leading to their unfortunate demise. This case highlights the aggressive nature of generalized melanosis, characterized by a rapid clinical course, substantial pigmentation, and limited response to conventional chemotherapy. Importantly, the patient had a BRAF mutation, emphasizing the urgency of exploring alternative treatment strategies. Patients with a BRAF mutation are excellent candidates for BRAF and MEK inhibitor treatment, potentially allowing them to extend their lifespan if this therapy were available. The challenges encountered in diagnosing, managing, and treating this aggressive form of metastatic melanoma underline the need for early detection, tailored therapeutic approaches, and ongoing research efforts to improve patient outcomes in such cases.<\/jats:p>","DOI":"10.3389\/fonc.2024.1332362","type":"journal-article","created":{"date-parts":[[2024,1,29]],"date-time":"2024-01-29T04:40:54Z","timestamp":1706503254000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Case report: Exceptional disease progression in a 70-year-old patient: generalized melanosis and melanuria in the course of metastatic melanoma - a case study"],"prefix":"10.3389","volume":"14","author":[{"given":"Jacek","family":"Calik","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Piotr","family":"Dzi\u0119giel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natalia","family":"Sauer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2024,1,29]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/J.BJPS.2022.04.093","article-title":"Location of cutaneous Malignant melanoma in Sweden 2004-2018 - mortality and sex differences","volume":"75","author":"\u00d6nef\u00e4ldt","year":"2022","journal-title":"J Plast Reconstr Aesthet Surg"},{"key":"B2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/CMR.0B013E32834E6AA0","article-title":"Superficial spreading and nodular melanoma are distinct biological entities: A challenge to the linear progression model","volume":"22","author":"Greenwald","year":"2012","journal-title":"Melanoma Res"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1002\/CNCR.23955","article-title":"Changes in the presentation of nodular and superficial spreading melanomas over 35 years","volume":"113","author":"Warycha","year":"2008","journal-title":"Cancer"},{"key":"B4","doi-asserted-by":"publisher","first-page":"298","DOI":"10.12865\/CHSJ.47.02.22","article-title":"Clinical study on the increased incidence of nodular melanoma cases compared to superficial melanoma","volume":"47","author":"Anghel-Savciu","year":"2021","journal-title":"Curr Heal Sci J"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1067\/MJD.2001.112349","article-title":"Diffuse melanosis arising from metastatic melanoma: pathogenetic function of elevated melanocyte peptide growth factors","volume":"44","author":"B\u00f6hm","year":"2001","journal-title":"J Am Acad Dermatol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.2165\/00128071-200809040-00007","article-title":"Acute kidney injury in a patient with melanuria, diffuse melanosis, and metastatic Malignant melanoma","volume":"9","author":"Gambichler","year":"2008","journal-title":"Am J Clin Dermatol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1038\/ki.2009.388","article-title":"The case a caucasian male with dark skin, black urine, and acute kidney injury","volume":"76","author":"Santos","year":"2009","journal-title":"Kidney Int"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1111\/J.1365-2559.1981.TB01787.X","article-title":"Pathogenesis of generalized melanosis with melanuria and melanoptysis secondary to Malignant melanoma","volume":"5","author":"Eide","year":"1981","journal-title":"Histopathology"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1111\/J.1365-2230.2009.03545.X","article-title":"Generalized melanosis and melanuria in a patient with metastatic melanoma","volume":"35","author":"Perez","year":"2010","journal-title":"Clin Exp Dermatol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2000.18.1.158","article-title":"Randomized phase III study of temozolomide versus dacarbazine in the treatment of patients with advanced metastatic Malignant melanoma","volume":"18","author":"Middleton","year":"2000","journal-title":"J Clin Oncol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/0190-9622(91)70096-K","article-title":"Diffuse melanosis in metastatic Malignant melanoma","volume":"24","author":"Steiner","year":"1991","journal-title":"J Am Acad Dermatol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1111\/J.0303-6987.2003.00154.X","article-title":"Diffuse melanosis after chemotherapy-induced tumor lysis syndrome in a patient with metastatic melanoma","volume":"31","author":"Busam","year":"2004","journal-title":"J Cutan Pathol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.3389\/FONC.2022.842496\/BIBTEX","article-title":"\u201cMelanoma, melanin, and melanogenesis: the yin and yang relationship,\u201d","volume":"12","author":"Slominski","year":"2022","journal-title":"Front Oncol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1111\/J.1755-148X.2011.00898.X","article-title":"\u201cL-tyrosine and L-dihydroxyphenylalanine as hormone-like regulators of melanocyte functions,\u201d","volume":"25","author":"Slominski","year":"2012","journal-title":"Pigment Cell Melanoma Res"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-5193(05)80292-9","article-title":"\u201cAre L-tyrosine and L-dopa hormone-like bioregulators?,\u201d","volume":"143","author":"Slominski","year":"1990","journal-title":"J Theor Biol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1111\/J.1600-0749.1989.TB00170.X","article-title":"L-tyrosine, L-DOPA, and tyrosinase as positive regulators of the subcellular apparatus of melanogenesis in Bomirski Ab amelanotic melanoma cells","volume":"2","author":"Slominski","year":"1989","journal-title":"Pigment Cell Res"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1242\/JCS.89.3.287","article-title":"\u201cPositive regulation of melanin pigmentation by two key substrates of the melanogenic pathway, l-tyrosine and l-dopa,\u201d","volume":"89","author":"Slominski","year":"1988","journal-title":"J Cell Sci"},{"key":"B18","doi-asserted-by":"publisher","first-page":"695","DOI":"10.5604\/17322693.1208033","article-title":"\u201cFrom tyrosine to melanin: Signaling pathways and factors regulating melanogenesis,\u201d","volume":"70","author":"Rzepka","year":"2016","journal-title":"Postepy Hig Med Dosw (Online)"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.3390\/LIFE13010181","article-title":"\u201cReview: the key factors to melanomagenesis,\u201d","volume":"13","author":"Mihulecea","year":"2023","journal-title":"Life"},{"key":"B20","unstructured":"NordlundJ\n            BoissyR\n            HearingV\n            KingR\n          The pigmentary system: physiology and pathophysiology2008"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1096\/fj.201701472R","article-title":"\u201cMelanin distribution in human epidermis affords localized protection against DNA photodamage and concurs with skin cancer incidence difference in extreme phototypes.,\u201d","volume":"32","author":"Fajuyigbe","year":"2018","journal-title":"FASEB J Off Publ Fed Am Soc Exp Biol"},{"key":"B22","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/J.ABB.2014.06.030","article-title":"\u201cThe role of melanogenesis in regulation of melanoma behavior: melanogenesis leads to stimulation of HIF-1\u03b1 expression and HIF-dependent attendant pathways,\u201d","volume":"563","author":"Slominski","year":"2014","journal-title":"Arch Biochem Biophys"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.7528","article-title":"\u201cMelanin content in melanoma metastases affects the outcome of radiotherapy.,\u201d","volume":"7","author":"Bro\u017cyna","year":"2016","journal-title":"Oncotarget"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1016\/j.mayocp.2014.02.009","article-title":"\u201cMelanoma resistance: a bright future for academicians and a challenge for patient advocates.,\u201d","volume":"89","author":"Slominski","year":"2014","journal-title":"Mayo Clinic Proc"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1159\/000018028","article-title":"Generalized melanosis in metastatic Malignant melanoma: the possible role of DOPAquinone metabolites","volume":"197","author":"Tsukamoto","year":"1998","journal-title":"Dermatology"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(96)90652-0","article-title":"Generalized melanosis caused by melanoma of the rectum","volume":"35","author":"Klaus","year":"1996","journal-title":"J Am Acad Dermatol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(89)70032-3","article-title":"Generalized melanosis in occult primary melanoma","volume":"20","author":"Snyder","year":"1989","journal-title":"J Am Acad Dermatol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.2340\/0001555573241250","article-title":"Two rare manifestations of melanomas: generalized cutaneous melanosis and rapid solar induction of showers of small pigmented lesions. A critical review of the literature and presentation of two additional cases","volume":"73","author":"Lerner","year":"1993","journal-title":"Acta Derm Venereol"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.5021\/AD.2015.27.6.780","article-title":"Diffuse cutaneous melanosis associated with Malignant melanoma","volume":"27","author":"Mangana","year":"2015","journal-title":"Ann Dermatol"},{"key":"B30","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1007\/BF00435223","article-title":"The impact of generalized Malignant melanoma on quality of life evaluated by the EORTC questionnaire technique","volume":"2","author":"Sigurdard\u00f3ttir","year":"1993","journal-title":"Qual Life Res"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199208203270811","article-title":"Disseminated melanoma\u2013is there a new standard therapy","volume":"327","author":"Guerry","year":"1992","journal-title":"N Engl J Med"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjms.2022.12.012","article-title":"Melanuria in a patient with BRAF-mutant metastatic melanoma of unknown primary: Insights on the pathophysiology, differential diagnosis, prognosis, and treatment","volume":"365","author":"Diamantopoulos","year":"2023","journal-title":"Am J Med Sci"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1016\/j.tins.2023.01.003","article-title":"\u201cHow cancer hijacks the body\u2019s homeostasis through the neuroendocrine system.,\u201d","volume":"46","author":"Slominski","year":"2023","journal-title":"Trends Neurosci"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1210\/edrv.21.5.0410","article-title":"\u201cNeuroendocrinology of the skin.,\u201d","volume":"21","author":"Slominski","year":"2000","journal-title":"Endocr Rev"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1152\/ajpcell.00147.2022","article-title":"\u201cNeuroendocrine signaling in the skin with a special focus on the epidermal neuropeptides.,\u201d","volume":"323","author":"Slominski","year":"2022","journal-title":"Am J Physiol Cell Physiol"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1117\/1.JBO.18.3.031107","article-title":"Two-photon excited fluorescence lifetime imaging and spectroscopy of melanins in vitro and in vivo","volume":"18","author":"Krasieva","year":"2013","journal-title":"J Biomed Opt"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2024.1332362\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,29]],"date-time":"2024-01-29T04:40:58Z","timestamp":1706503258000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2024.1332362\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,29]]},"references-count":36,"alternative-id":["10.3389\/fonc.2024.1332362"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2024.1332362","relation":{},"ISSN":["2234-943X"],"issn-type":[{"type":"electronic","value":"2234-943X"}],"subject":[],"published":{"date-parts":[[2024,1,29]]},"article-number":"1332362"}}